We have discovered a novel interaction between the growth factor progranulin and the F-actin-binding protein drebrin and provide several lines of evidence that underscore a key role for drebrin in regulating progranulin bioactivity in bladder cancer. The gene discussed is DBN1; the disease is urinary bladder cancer.